Publicações

Analysis of Autonomic Outcomes in Apollo, a Phase Iii Trial of the Rnai Therapeutic Patisiran in Patients with Hereditary Transthyretin-Mediated Amyloidosis (Vol 264, Pg 703, 2020)

AuthID
P-00R-TG8

Author(s)

Gonzalez Duarte, A

Berk, JL

Quan, DN

Mauermann, ML

Schmidt, HH

Polydefkis, M

Waddington Cruz, M

Ueda, M

Conceicao, IM

Kristen, AV

Coelho, T

Cauquil, CA

Tard, C

Merkel, M

Aldinc, E

Chen, JH

Sweetser, MT

Wang, JJ

Adams, D

Tipo de Documento

Correction

Year published

2020

Publicado

in JOURNAL OF NEUROLOGY, ISSN: 0340-5354

Volume: 267, Número: 3, Páginas: 713-714 (2)

Indexing

Wos^®

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1007/s00415-020-09715-5

Wos: WOS:000515353700017

Source Identifiers

ISSN: 0340-5354

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

Analysis of Autonomic Outcomes in Apollo, a Phase Iii Trial of the Rnai Therapeutic Patisiran in Patients with Hereditary Transthyretin-Mediated Amyloidosis (Vol 264, Pg 703, 2020)

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Analysis of Autonomic Outcomes in Apollo, a Phase Iii Trial of the Rnai Therapeutic Patisiran in Patients with Hereditary Transthyretin-Mediated Amyloidosis (Vol 264, Pg 703, 2020)

Links Úteis

Ajuda